Heron Therapeutics, Inc.

Heron Therapeutics is a biotechnology company that develops and commercializes pharmaceutical products. The company’s research and development pipeline relies on animal testing to assess the safety and efficacy of its drug candidates, a standard practice in the industry for regulatory approval. Preclinical studies for its products, as documented in scientific literature, utilize in vivo models in rodents and non-human primates.

While the provided evidence does not detail a specific pattern of animal welfare violations unique to Heron, the company’s business model is inherently dependent on animal experimentation. This places it within the broad category of commercial animal exploitation for product development, as it does not fall under a more specific exclusion code such as animal testing for cosmetics. The company has not publicly disclosed a commitment to adopting or funding advanced non-animal testing methodologies.